In Depth 11 Jun 2025 Can gene therapy treat vision loss? …First of all, the eye is an immune-privileged area of the body where the immune system has restricted access. This prevents immune reactions against the viral vector used to deliver… June 11, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Inside Labiotech 30 Nov 2017 Why is Erik Digman Wiklund, CFO of Targovax, reading Labiotech.eu? …see more of? A weekly synthesis of the top industry news and events – how about in the form of a podcast? More coverage on how investors and big pharma… November 30, 2017 - 2 minutesmins - By Katherine Douglas Share WhatsApp Twitter Linkedin Email
News and Trends 5 Nov 2018 Series C Bags German Company €17M for Irregular Heartbeat Treatment …purified fish oil reduced the risk of cardiovascular events by 25% in Phase III. “The generally mixed results of clinical trials using omega-3 fatty acids are, from our perspective, a… November 5, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 18 Aug 2022 CSL gets positive results for preventive treatment in patients with hereditary angioedema …of events leading to edema formation. By targeting FXIIa, garadacimab inhibits the HAE cascade at its origin as compared with other HAE therapies that target downstream mediators. Clinical programs Garadacimab… August 18, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 21 Mar 2017 Rethinking Profits: Can a Socially Conscious Model work in Biotech? …through a transfer to another charitable or asset-locked company; this setup prevents them from being stripped in an acquisition. “I think it’s a bit of a shame that biotech and… March 21, 2017 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 19 Dec 2022 Jacobio’s cancer treatment given breakthrough therapy designations by China CDE …JAB-21822 has a good safety profile, and most treatment related adverse events (TRAE) were grade 1-2. Among the 72 patients, the incidences of diarrhea and vomiting were 5.6% and 6.9%… December 19, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
More News! 27 Jun 2019 German Biotech Will Target Parkinsonian Disorders with €12M Series A …is a rare disorder, with similar symptoms to Parkinson’s disease, that is caused by breakdown of neurons in parts of the brain. The German biotech’s drug candidate prevents and stops… June 27, 2019 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Inside Labiotech 28 Nov 2019 How Remote Working Helps Us Become a Productive and Happy Team …always these little things that make the difference. Beware of flagging team spirit If you can, avoid remote work during important company events. It’s probably the only time outside work… November 28, 2019 - 12 minutesmins - By Yi-Jen Chang Share WhatsApp Twitter Linkedin Email
News and Trends 17 Mar 2023 Beyond Biotech podcast 38: Hello Tomorrow Global Summit …epigenetics and 3D genome structures through data and machine learning to design high precision gene-editing systems. The company’s platform enables the design of appropriate gene editing apparatus. It prevents editing… March 17, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jul 2020 Hansa Biopharma Gets up to €350M to Make Gene Therapy Work in Resistant Patients …antibodies against AAV. This prevents the transfer of the healthy gene sequence and raises safety concerns for the patient. Swedish company Hansa Biopharma is developing a pretreatment called imlifidase that… July 7, 2020 - 2 minutesmins - By Antara Mazumdar Share WhatsApp Twitter Linkedin Email
Opinion 29 Nov 2023 Redefining drug development: the trailblazing evolution of the pharmaceutical industry …to replicate patient profiles virtually, can bring in a new era of personalized medicine. They are able to negate the necessity for in-person placebo groups, invasive procedures, or events causing… November 29, 2023 - 9 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 4 Sep 2017 Record Momentum for European Biotech …our IPO, Euronext was the best choice given the number of listed biotech SMEs, of biotech investors, brokers and biotech-related events, as well as the strong and supportive EU regulatory… September 4, 2017 - 10 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email